- Home
- GRWG vs CTOR Comparison
GRWG vs CTOR Comparison
Compare GRWG & CTOR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- GRWG
- CTOR
- Stock Information
- Founded
- GRWG 2008
- CTOR 2021
- Country
- GRWG United States
- CTOR United States
- Employees
- GRWG N/A
- CTOR N/A
- Industry
- GRWG RETAIL: Building Materials
- CTOR
- Sector
- GRWG Consumer Discretionary
- CTOR
- Exchange
- GRWG Nasdaq
- CTOR NYSE
- Market Cap
- GRWG 88.9M
- CTOR 89.9M
- IPO Year
- GRWG N/A
- CTOR N/A
- Fundamental
- Price
- GRWG $1.49
- CTOR $1.22
- Analyst Decision
- GRWG Hold
- CTOR Strong Buy
- Analyst Count
- GRWG 5
- CTOR 2
- Target Price
- GRWG $2.75
- CTOR $4.50
- AVG Volume (30 Days)
- GRWG 708.5K
- CTOR 169.0K
- Earning Date
- GRWG 03-12-2025
- CTOR 02-21-2025
- Dividend Yield
- GRWG N/A
- CTOR N/A
- EPS Growth
- GRWG N/A
- CTOR N/A
- EPS
- GRWG N/A
- CTOR N/A
- Revenue
- GRWG $200,882,000.00
- CTOR N/A
- Revenue This Year
- GRWG N/A
- CTOR N/A
- Revenue Next Year
- GRWG N/A
- CTOR N/A
- P/E Ratio
- GRWG N/A
- CTOR N/A
- Revenue Growth
- GRWG N/A
- CTOR N/A
- 52 Week Low
- GRWG $1.49
- CTOR $0.85
- 52 Week High
- GRWG $3.38
- CTOR $49.00
- Technical
- Relative Strength Index (RSI)
- GRWG 34.09
- CTOR N/A
- Support Level
- GRWG $1.51
- CTOR N/A
- Resistance Level
- GRWG $1.58
- CTOR N/A
- Average True Range (ATR)
- GRWG 0.10
- CTOR 0.00
- MACD
- GRWG -0.01
- CTOR 0.00
- Stochastic Oscillator
- GRWG 2.56
- CTOR 0.00
About GRWG GrowGeneration Corp.
GrowGeneration Corp owns and operates specialty retail hydroponic and organic gardening stores. The firm is a marketer and distributor of nutrients, growing media, advanced indoor and greenhouse lighting, ventilation systems and accessories for hydroponic gardening. The Company has two reportable segments, including Cultivation and Gardening segment, composed of the Company's hydroponic and organic gardening business; and the Storage Solutions segment, composed of the Company's benching, racking, and storage solutions business.
About CTOR CITIUS ONCOLOGY INC
Citius Oncology Inc is a specialty pharmaceutical company dedicated to the development and commercialization of critical care products targeting unmet needs with a focus on oncology products. In addition, Citius completed enrollment in its Phase 2b trial of CITI-002 (Halo-Lido), a topical formulation for the relief of hemorrhoids.